MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Sagent Pharmaceuticals Company Profile (NASDAQ:SGNT)

Consensus Ratings for Sagent Pharmaceuticals (NASDAQ:SGNT) (?)
Ratings Breakdown: 2 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $27.75 (12.90% upside)

Analysts' Ratings History for Sagent Pharmaceuticals (NASDAQ:SGNT)
Show:
DateFirmActionRatingPrice TargetActions
6/6/2015Raymond JamesReiterated RatingBuy$21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/3/2015Raymond JamesInitiated CoverageStrong-Buy$31.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/7/2015Deutsche BankInitiated CoverageBuy -> Buy$29.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/20/2015RBC CapitalBoost Price TargetSector Perform$31.00 -> $34.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/17/2014Jefferies GroupLower Price TargetHold$33.00 -> $27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/3/2014Jefferies GroupReiterated RatingHold$25.00 -> $33.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/31/2014RBC CapitalBoost Price TargetSector Perform$20.00 -> $27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/31/2014JPMorgan Chase & Co.Boost Price TargetNeutral$24.00 -> $27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/31/2014Jefferies GroupBoost Price TargetHold$23.00 -> $25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/31/2014Needham & Company LLCDowngradeBuy -> Hold$25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/25/2014S&P Equity ResearchDowngradeBuy -> Neutral$25.00 -> $28.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/25/2014Bank of AmericaDowngradeBuy -> Neutral$25.00 -> $28.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/15/2014Jefferies GroupReiterated RatingHold$23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2014JPMorgan Chase & Co.Reiterated RatingHold$22.00 -> $24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2014Jefferies GroupReiterated RatingHold$23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/29/2014Jefferies GroupReiterated RatingHold$23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/21/2014Jefferies GroupInitiated CoverageHold$23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/12/2014JPMorgan Chase & Co.Reiterated RatingNeutral$24.00 -> $22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/7/2014Bank of AmericaUpgradeNeutral -> Buy$26.00 -> $25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/6/2014RBC CapitalInitiated CoverageUnderperform$22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/11/2013RBC CapitalUpgradeSector Perform -> Outperform$22.00 -> $25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/21/2013RBC CapitalBoost Price TargetSector Perform$19.00 -> $22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/7/2013JPMorgan Chase & Co.Boost Price Target$18.00 -> $21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/7/2013Jefferies GroupBoost Price TargetBuy$21.00 -> $27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/7/2013Needham & Company LLCBoost Price TargetBuy$20.00 -> $25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 8/2/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha